Relmada Therapeutics
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.About RLMD
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications.
CEOSergio Traversa
CEOSergio Traversa
Employees10
Employees10
HeadquartersCoral Gables, Florida
HeadquartersCoral Gables, Florida
Founded2012
Founded2012
Employees10
Employees10
RLMD Key Statistics
Market cap124.16M
Market cap124.16M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume261.00K
Average volume261.00K
High today$4.44
High today$4.44
Low today$4.07
Low today$4.07
Open price$4.22
Open price$4.22
Volume246.86K
Volume246.86K
52 Week high$38.68
52 Week high$38.68
52 Week low$1.81
52 Week low$1.81
Analyst ratings
67%
of 6 ratingsBuy
33.3%
Hold
66.7%
Sell
0%
RLMD Earnings
-$2.44
-$1.63
-$0.81
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 22, After Hours
ActualExpected Mar 22, After Hours